FDA

News

Amgen nabs speedy approval for first-ever KRAS drug sotorasi...

After decades of mostly unsuccessful R&D, Amgen has claimed the first ever regulatory approval for a drug that inhibits KRAS – a cancer target that for a long time was all-but written o

News

scientifically visualization of a coronavirus spike protein

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

GlaxoSmithKline's COVID-19 drive has advanced on two fronts, with the start of phase 3 trials of its Sanofi-partnered vaccine candidate as well as an FDA emergency approval for antibody sot

News

FDA fires broadside at CytoDyn over COVID-19 antibody data

In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19.

News

FDA authorises Pfizer/BioNTech vaccine for adolescents

The FDA has authorised Pfizer/BioNTech’s vaccine for 12- to 15 year-olds under emergency rules.

News

MDMA on track for 2023 approval as PTSD therapy, says develo...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the org

News

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

The FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to investigate inhaled drugs.

Amgen nabs speedy approval for first-ever KRAS drug sotorasi...

GSK, Sanofi eye Q4 approval as COVID jab starts phase 3

FDA fires broadside at CytoDyn over COVID-19 antibody data

FDA authorises Pfizer/BioNTech vaccine for adolescents

MDMA on track for 2023 approval as PTSD therapy, says develo...

FDA extends tie-up with CN Bio to test 'lung-on-a-chip' tech

Third Rock in $2bn drug-hunting pact with China's Funnel

Securing your ROI: Turning post-acquisition integration into...

FDA

Editor's Picks